Literature DB >> 18823780

Statin use and the risk of Parkinson disease: a nested case control study.

Ali Samii1, Bruce C Carleton, Mahyar Etminan.   

Abstract

Using the British Columbia Linked Health Databases, we explored the association between the use of statin drugs and the risk of developing Parkinson disease (PD). We followed a cohort of older adults in the Province of British Columbia from 1997 to 2003. Using a study design of nested case control (case-control study within a cohort), the relative risk of developing PD for statin users was 0.94 (0.82-1.09). Our study did not show a statistically significant effect on the risk of PD with statin use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823780     DOI: 10.1016/j.jocn.2008.01.016

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  12 in total

1.  Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.

Authors:  Xuemei Huang; Alvaro Alonso; Xuguang Guo; David M Umbach; Maya L Lichtenstein; Christie M Ballantyne; Richard B Mailman; Thomas H Mosley; Honglei Chen
Journal:  Mov Disord       Date:  2015-01-14       Impact factor: 10.338

2.  Statin use and Parkinson's disease in Denmark.

Authors:  Beate Ritz; Angelika D Manthripragada; Lei Qian; Eva Schernhammer; Lene Wermuth; Jorgen Olsen; Soren Friis
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

3.  Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.

Authors:  Krishna Undela; Kapil Gudala; Swathi Malla; Dipika Bansal
Journal:  J Neurol       Date:  2012-07-21       Impact factor: 4.849

4.  Prospective study of statin use and risk of Parkinson disease.

Authors:  Xiang Gao; Kelly C Simon; Michael A Schwarzschild; Alberto Ascherio
Journal:  Arch Neurol       Date:  2012-03

5.  Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.

Authors:  Guodong Liu; Nicholas W Sterling; Lan Kong; Mechelle M Lewis; Richard B Mailman; Honglei Chen; Douglas Leslie; Xuemei Huang
Journal:  Mov Disord       Date:  2017-04-03       Impact factor: 10.338

6.  Association between Statin Use and Risk of Parkinson's Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals.

Authors:  Chieh-Chen Wu; Md Mohaimenul Islam; An-Jen Lee; Chun-Hsien Su; Yung-Ching Weng; Chih-Yang Yeh; Hsun-Hua Lee; Ming-Chin Lin
Journal:  J Pers Med       Date:  2022-05-19

Review 7.  Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.

Authors:  Alexander Grotemeyer; Rhonda Leah McFleder; Jingjing Wu; Jörg Wischhusen; Chi Wang Ip
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

8.  Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis.

Authors:  Shuang Bai; Yi Song; Xin Huang; Lidan Peng; Jie Jia; Yu Liu; Hong Lu
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

9.  Integrated molecular landscape of Parkinson's disease.

Authors:  J E Visser; G Poelmans; C J H M Klemann; G J M Martens; M Sharma; M B Martens; O Isacson; T Gasser
Journal:  NPJ Parkinsons Dis       Date:  2017-04-10

10.  α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.

Authors:  Clive Bate; Alun Williams
Journal:  Biomolecules       Date:  2015-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.